The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, two-period, crossover trial to evaluate the pharmacokinetic
profiles of albumin-bound docetaxel for intravenous infusion and Taxotere in patients with
advanced solid tumors.